-
1دورية أكاديمية
المؤلفون: M Siringo, F Larocca, A Spagnuolo, G Gentile, M Anile, D Diso, D Santini, A Gelibter
المصدر: Current Problems in Cancer: Case Reports, Vol 14, Iss , Pp 100291- (2024)
مصطلحات موضوعية: Nsclc, Alk tyrosine kinase inhibitor, Kras g12c mutation, NGS, oncogenic driver mutations, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2666621924000140Test; https://doaj.org/toc/2666-6219Test
-
2دورية أكاديمية
المؤلفون: Vavalà, Tiziana, Novello, Silvia
المساهمون: Vavalà, Tiziana, Novello, Silvia*
مصطلحات موضوعية: alectinib, alectinib clinical trial, ALK, ALK inhibitor, ALK-rearranged NSCLC, ALK–TKI, ALK–tyrosine kinase inhibitor, EML4–ALK, non-small cell lung cancer, NSCLC, Oncology
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30090122; info:eu-repo/semantics/altIdentifier/wos/WOS:000442650700001; volume:10; firstpage:///; lastpage:///; numberofpages:///; journal:THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY; http://hdl.handle.net/2318/1685288Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85054839982; http://tam.sagepub.com/content/by/yearTest
الإتاحة: https://doi.org/10.1177/1758835918789364Test
http://hdl.handle.net/2318/1685288Test
http://tam.sagepub.com/content/by/yearTest